VIRTUAL MEETING NOW AVAILABLE

Registered Delegates, who already signed up and paid for Virtual Meeting

Click here to get access >>

Username: <Your registration ID number>
Password: <Your Family Name>

Registered Delegates, who have not yet signed up and paid for Virtual Meeting

Click here to purchase the Virtual Meeting >>

IASLC Members: 40 Euro
Non IASLC Members: 70 Euro

Non-Registered Delegates

Click here to purchase the Virtual Meeting >>

IASLC Members: 300 Euro
Non IASLC Members: 700 Euro

ePOSTERS NOW AVAILABLE

Click here to access the ePoster system >>

Itinerary Builder incl. full Scientific Programme and Abstracts now available.

Search for authors, presenters, topics, sessions, abstracts, keywords or topics, highlight any sessions and/or presentations of interest and create your own WCLC 2011 itinerary.

Click here to get access to the full Scientific Programme >>

07:00 - 11:00

Young Investigator's Session incl. Breakfast and Coffee Break

Location: Elicium I

Chairs: Kwun Fong, Australia, Suresh Senan, Netherlands, Gavin Wright, Australia & Femke Spoelstra, Netherlands

• How to Plan an Academic Career in Lung Cancer - David S. Ettinger, USA
• How to Present Data for and on a Congress - Michael Boyer, Australia
• How to Write a Grant Application for IASLC - Karen Kelly, USA
• Using the Published Literature Effectively - Fergus Macbeth, UK
• The Future Role of Different Specialists in Multimodality Medicine (Lung Cancer)
  • Medical Oncologist: Enriqueta Felip Font, Spain
  • Pathologist: Andrew G. Nicholson, UK
  • Pulmonologist: Elisabeth Quoix, France
  • Radiotherapist: Billy W. Loo, USA
  • Surgeon: Gavin Wright, Australia
• Improving Access to Education and Cancer Care in Developing Countries - Michael Barton, Australia
• An Example of a Multidisciplinary Patient and Treatment Decision Meeting - Emile Comans, The Netherlands

11:00 - 13:00

Johns Hopkins University Symposium supported by an educational grant from Eli Lilly: Histology Matters: Personalized Therapy for Patients with NSCLC

Location: Elicium II

• Radiotherapy
  • HO1.1: Implementing Image Guided (IGRT) and Stereotactic Ablative Radiotherapy (SBRT)
  • HO1.2: Demonstration Multidisciplinary Meeting for Treatment Decision Making
  • HO1.3: Teaching Course on SBRT and Other Image Guided RT Techniques for Lung Cancer in Practic
• HO2: PET: Optimizing Interpretation by E-Learning
• HO3: Statistical Course - Fundamental Statistics for Clinical Researchers
• HO4: EGFR Mutation and ALK Testing Methods in Diagnostic Pathology
• Endoscopy
  • HO6.1: Interactive Stop and Go - CANCELLED
  • HO6.2: E-Ultrasound for Lymph Node Staging - FULL
  • HO6.3: Pleural (with Mesothelioma)
  • HO6.4: Early Detection and Endobronchial Therapy
  • HO6.5: Rigid Bronchoscopy and Airway Stenting
  • HO6.6: Management of Upper Airway and Massive Haemoptysis

13:30 - 15:00

NEW DATE & TIME!

Addario Lung Cancer Medical Institute (ALCMI) Symposium: The Way Forward for Molecular Diagnosis and Treatment in Lung Cancer
Chairs: Giorgio Scagliotti, Italy & Rafael Rosell, Spain

Location: Elicium I

• Introduction:  Challenges and Opportunities for the next 5 years
• The Time is Now:  Biospecimen Collection, Networking and Fast-Track Molecular Analyses — Harvey I. Pass, USA
• Integration of Molecular Testing into Clinical Workflow and Informed Decision-Making — David P. Carbone, USA
• Accelerating Discoveries to Patients:  Driving Academic - Industry Collaborations — David M. Jablons, USA
• Addario Lung Cancer Medical Institute:  A Collaborative Model for Biospecimen Collections and Translational Research — Steven W. Young, USA
• Impact of Advocacy Organizations:  a Case Study on Patient-Founded/Funded/Focused Transformational Research Efforts — Bonnie J. Addario, USA
• Panel Discussion:  Catalyzing Effective International Collaborations to Make Lung Cancer a Survivable Disease — Bonnie J. Addario, USA, David P. Carbone, USA, David M. Jablons, USA, David R. Gandara, USA, David M. Jablons, USA, Pasi A. Janne, USA, Silvia Novello, Italy, Harvey I. Pass, USA, Rafael Rosell, Spain, Steven W. Young, USA

15:00 - 17:00

The International Thoracic Oncology Nurses Forum (ITONF) - Meeting the Needs of Nurses

Location: Forum

Chair: Glenda Colburn, Australia

• Welcome - John McPhelim, UK
• Keynote Address - Cancer Nursing International Collaboration - Nora Kearney, UK
• ITONF Official Launch: From The Beginning - Liz Darlison, UK & Beth Ivimey, Australia
• Establishing a National Forum: The UK NLCNF Experience - Maria Guerin, UK
• The Netherlands Experience in Lung Cancer Nursing: FORUMS - Christa Putker-Hatzmann, The Netherlands
• Open Discussion, Questions and Way Forward - Facilitators & Mary Duffy, Australia
• The Week Ahead - WCLC Program Discussion & Networking Sessions - John McPhelim, UK

16:00 - 18:00

Symposium supported by AstraZeneca: EGFR Mutation-Positive Advanced NSCLC: Optimising Treatment Sequences Based on Molecular Biology

Location: Auditorium

18:00 - 21:00

Opening Ceremony & Welcome Reception

Location:
Opening Cermony - Plenary Hall
Welcome Reception - Exhibit Hall

07:00 - 08:00

Concurrent Industry Supported Symposium

• Symposium supported by Varian Medical Systems: Expanding Options For High Risk Operable Early-Stage NSCLC Patients

Location: Elicium I

• IMER Symposium supported by an educational grant from Genentech and Bristol-Myers Squibb Company: The Emerging and Evolving Role of Personalized Therapy in Non-Small Cell Lung Cancer (NSCLC)

Location: Forum

• MTE01: Small Cell Lung Cancer, Para Neoplastic Syndromes - Harry J.M. Groen, Netherlands & Maarten Titulaer, USA

Location: E102

• MTE02: Treatment of Mesothelioma - New Pathways - Emanuela Felley-Bosco, Switzerland & Courtney Broaddus, USA

Location: E103

• MTE03: Adenocarcinoma Classification Update - Pathology and Radiology - William Travis, USA & Kavita Garg, USA

Location: E104-E105

• MTE04: Molecular Markers in Lung Cancer - Luis Montuenga, Spain

Location: E106-E107

• MTE05: Integral Approach Nodal/Mediastinal Disease PET/EBUS/EUS - Tawimas Shaipanich, Canada & Sigrid Stroobants, Belgium

Location: E108

• MTE06: New Technology in Radiotherapy - We Do not Need Phase III Trials - Pro / Con - Dirk De Ruysscher, Netherlands & David Ball, Australia

Location: G102

• MTE07: Non-Small Cell Lung Cancer with Synchrosnous Brain Metastases: When is Aggressive Treatment Justified? - Frank J Lagerwaard, Netherlands & Corey J. Langer, USA

Location: G103

• MTE08: Surgery for Mesothelioma Pleurectomy - EPP - Brian McCaughan, Australia & David Waller, UK

Location: G104-G105

• MTE09: Sleeve Resections - Erino Rendina, Italy & Valerie Rusch, USA

Location: G106-G107

PL01: The Lung Cancer Epidemic
Chairs: Carolyn Dresler, USA & Jan Willem Coebergh, Netherlands

Location: Plenary Hall

• Current Trends and Regional Differences - Richard Peto, UK
• Lung Cancer Susceptibility Genes - Thorgeir E. Thorgeirsson, USA
• Lung Cancer Survival: Striking Regional Differences - Jan Willem Coebergh, Netherlands
• Changing Histopathological Picture of Lung Cancer? - Douglas Flieder, USA

10:00 - 11:00

IASLC Press Conference - CT Screening

Location: G109

10:00 - 10:30

Coffee Break

Location: Exhibit Hall

O01: Conference President's Selection
Chairs: Peter Goldstraw, UK & Pieter Postmus, Netherlands

Location: Auditorium

O01.01 - Overall survival improvement in patients with lung cancer treated with denosumab versus zoledronic acid: Results from a randomized phase 3 study - Giorgio Scagliotti, Italy

O01.02 - Randomized phase 3 trial of amrubicin versus topotecan as second-line treatment for small cell lung cancer (SCLC) - Joachim von Pawel, Germany

O01.03 - British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50mg/m2 (GC50) versus cisplatin 80mg/m2 (GC80) versus carboplatin AUC 6 (GCb6) in advanced NSCLC - David Ferry, UK

Discussant: Siow Ming Lee, UK

O01.05 - PARAMOUNT: Phase III trial results of maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC) - Luis Paz Ares, Spain

O01.06 - Epidermal growth factor receptor (EGFR) expression as a predictor of survival for first-line chemotherapy plus cetuximab in FLEX study patients with advanced non-small cell lung cancer (NSCLC) - Robert Pirker, Austria

O01.07 - Large-Scale International Validation of a qPCR-Based Genetic Assay Prognostic of Survival in Resected Non-Squamous Cell Lung Cancer - Johannes Kratz, USA

Discussant - Giorgio Scagliotti, Italy

E01: Education Session: Treatment of Mesothelioma
Chairs: Paul Baas, Netherlands & Harvey Pass, USA

Location: E106 - E107

• Immunological Treatment in MPM - Daniel H. Sterman, USA
• Update on Multimodality Treatment (including Surgery) in MPM - Harvey Pass, USA
• MPM Guidelines in the Year 2011 - Arnaud Scherpereel, France
• What is the Future of Biomarkers in MPM? - Bruce Robinson, Australia

E02: Education Session: Imaging for Radiotherapy Planning and Adaptive Planning
Chairs: Caro Koning, Netherlands & Andrea Bezjak, Canada

Location: E104-E105

• Current Role of 4D PET Scans - Wouter van Elmpt, Netherlands
• Role of Intrafractional and Adaptive Imaging - Jan Jakob Sonke, Netherlands
• Advances in On-Board Image-Guidance - Matthias Guckenberger, Germany
• Role of PET Scans in Radiotherapy - Prognosis and Target Definition - Michael MacManus, Australia

E03: Education Session: Borderline Operable NSCLC
Chair: Dominique Grunenwald, France & Ben Slotman, Netherlands

Location: E102

• Who is a Borderline Operable Patient? - Ramon Rami-Porta, Spain
• What is Optimal Surgery in a Borderline Operable Patient? - Nasser Altorki, USA
• Outcome of SBRT in Patients with Poor Lung Function - Jose Belderbos, Netherlands

M01: Mini Symposium: Signaling in Lung Cancer
Chairs: Fred Hirsch, USA & Jin Soo Lee, Korea

Location: G103

• Pharmacogenetics - Phillip Mack, USA
• EML4-ALK Fusion Gene - Ben Solomon, Australia
• Pathways Pathogenesis - Celine Mascaux, Belgium
• Deregulation of Chromatin Remodeling in Lung Cancer - Adi Gazdar, USA

M02: Mini Symposium: K-Ras Role in NSCLC
Chairs: Rafael Rosell, Spain & Frances Shepherd, Canada

Location: Elicium II

• K-ras Biology - Rafael Rosell, Spain
• Is K-Ras Mutated NSCLC a Distinct Form of NSCLC? - Benjamin Besse, France
• Synthetic Lethal Approaches to Tackle RAS Mutant NSCLC - Ji Luo, USA
• Clinical Approach to K-Ras Mutant NSCLC - Frances Shepherd, Canada

M03: Mini Symposium: Carcinogenesis and Metastasis
Chairs: Yasushi Yatabe, Japan & Wilbur Franklin, USA

Location: G104-G105

• Molecular Pathogenesis of Squamous Cell Carcinoma and its Precursor Lesions - Wilbur Franklin, USA
• Molecular Pathogenesis of Adenocarcinoma and its Precursor Lesions - Masayuki Noguchi, Japan
• Molecular Pathogenesis of Neuroendocrine and its Precursor Lesions - Yuichi Ishikawa, Japan
• Biology of Metastasizing Lung Cancer - Lucian Chirieac, USA

M04: Mini Symposium: Issues Surrounding the Use of PFS as a Primary Endpoint
Chairs: Otilia Dalesio, Netherlands & John Crowley, USA

Location: G106-G107

• The Statistician Perspective - Sumithra Mandrekar, USA
• The Medical Perspective - Mark Socinski, USA
• The Regulatory Perspective (Europe) - Francesco Pignatti, UK
• Discussion - John Crowley, USA

M05: Mini Symposium: Tracheal Tumors
Chairs: Georgios Stamatis, Germany & Bernward Passlick, Germany

Location: Elicium I

• Endobronchial Treatment - Herve Dutau, France
• Resection and Reconstruction - Georgios Stamatis, Germany
• Role of Adjuvant Radiotherapy in the Surgical Treatment of Tracheal Carcinoma - Henning A. Gaissert, USA
• Tracheal Transplants - Emmanuel Martinod, France

M06: Mini Symposium: Global Lung Cancer Coalition (GLCC) and Longkanker Informatiecentrum: Lung Cancer - Effecting Change
Chairs: Matthew Peters, Australia & Harry Groen, Netherlands

Location: G102

• Global Attitudes to Lung Cancer - Robert Worcester, UK
• Lung Cancer and the Internet - Cilia Linssen, Netherlands
• Lung Cancer and the New Media - Tracy Fischer, USA
• New Technology to Effect Change in Lung Cancer Outcomes - Jim Mulshine, USA
• Lung Cancer Specialist Nurses - Showing their Worth - Beth Ivimey, Australia
• Discussion - All Speakers

GR01: Grand Rounds Session: Boundaries of Bronchoscopy: Central Hilar Lesions
Chairs: Felix Herth, Germany
Experts:
Pathology/Mol. Biology - Elisabeth Brambilla, France
Nucl. Med/Radiology - Emile E. Comans, Netherlands
Radiation Oncology - Cornelis Haasbeek, Netherlands
Surgery - Ugo Pastorino, Italy
Int. Pulmonology - Kiyoshi Shibuya, Japan

Location: Forum

• A Subsequent Primary in an COPD Patient with Previous Lobectomy/Penumonectomy - Hans Daniels, Netherlands
• A Case of Synchronous Double Squamous Primares - Hidetoshi Honda, Japan
• A Case of COPD and Lung Cancer and Lung Cancer Treated Repeatedly with Intraluminal Treatment Resulting in Prolonged Survival - Bing Lam, Hong Kong
• Discussion - All Speakers

12:15 - 14:15

Poster and ePoster Session (Exhibit Hall)

Poster presenters are available to discuss their Poster with delegates

Poster Session P1

Topics:

• Cancer Biology
• Technology and Models
• Surgery
• Novel Cancer
• Radiotherapy

ePosters

Mini Oral presenters are available at pre-defined ePoster stations to discuss their extended Mini Oral presentation being presented in the Mini Oral Sessions from 14:30 to 16:00 that day (corresponding Mini Oral Sessions MO01 - MO06)

12:15 - 14:15

Professional Education Services Group Symposium supported by an educational grant from Eli Lilly: The Evolution From Empiric to Personalized Treatment The Interrelationship of Histology, Biomarkers, and Maintenance Therapy

Location: Plenary Hall

O02: Oral Session: Radiation Oncology I

Location: Auditorium

O03: Oral Session: Surgery - Staging

Location: Forum

O04: Oral Session: Classical Pathology: Adenocarcinoma

Location: E102

O05: Oral Session: Molecular Pathology I, ALK

Location: E103

O06: Oral Session: Biomarkers I

Location: E104-E105

O07: Oral Session: Genetics and Epigenetics

Location: E106

O08: Oral Session: Palliative and Supportive Care

Location: E107

O09: Oral Session: SCLC I

Location: E108

O10: Oral Session: Medical Oncology I

Location: Elicium I

O11: Oral Session: Medical Oncology V

Location: Elicium II

O12: Oral Session: Epidemiology I

Location: D201

O13: Oral Session: Clinical Cases and Clinical Decisions I

Location: G102

MO01: Mini Oral Session: Mesothelioma and Thymoma

Location: G102

MO02: Mini Oral Session: Concurrent Chemoradiotherapy Combined With New Drugs and New Radiotherapy Schemes and Techniques

Location: G103

MO03: Mini Oral Session: Prognostic Factors and Stage

Location: G104

MO04: Mini Oral Session: Biomarkers VI

Location: G105

MO05: Mini Oral Session: CT Screening of Individuals At Risk and Epidemiology

Location: G106

MO06: Mini Oral Session: PET, SPECT and CT in the Initial Staging and Response Assessment in NSCLC

Location: G107

E04: Education Session: Imaging Aspects of Staging in Lung Cancer
Chairs: Johny Verschakelen, Belgium & Otto Hoekstra, Netherlands

Location: Forum

• Use and Challenges for the Use of PET-CT in NSCLC - Walter de Wever, Belgium
• New IASLC Staging System: Implications for CT-Reading - Homer Macapinlac, USA
• EBUS and EUS for N-Staging in NSCLC - Kazuhiro Yasufuku, Canada

Case Presentations
Case Presenter: Daniela E. Oprea-Lager, Netherlands
Case Presenter: Mark Onaitis, USA
Case Presenter: Idris Bahce, Netherlands

Experts:
Radiologist: Johny Verschakelen, Belgium
Pulmonologist: Pieter Postmus, Netherlands
Surgeon: Paul de Leyn, Belgium
NM Physician: Homer Macapinlac, USA

E05: Education Session: Diagnosis and Treatment Decisions
Chairs: Kenneth O'Byrne, Ireland & Erik Thunnissen, Netherlands

Location: E102

• Distinction Between Adenocarcinoma and Squamous Cell Carcinoma - Keith M. Kerr, UK
• Distinction Between SCLC and LCNEC - Mary Beth Beasley, USA
• Distinction Between Second Primary and Metastases - Sanja Dacic, USA
• Cytological Diagnosis of Lung Cancer: Opportunities and Limitations - Maureen Zakowski, USA

E06: Education Session: Quality Control and Concentration of Care
Chairs: Eric Vallieres, USA

Location: E106

• US Concentration of Care - Eric Vallieres, USA
• Europe Concentration of Care - Walter Klepetko, Austria
• Quality Control Through Surgical Guidelines - Masahiro Tsuboi, Japan
• Thoughts on Training - Dirk van Raemdonck, Belgium

E07: Education Session: Organising Lung Cancer Nursing
Chairs: Carolyn Clary-Macy, USA & Liz Darlison, UK

Location: E107

• A Complex Intervention for the Management of a Respitory Distress Symptom Cluster (Breathlessness, Cough & Fatigue) in Patients with Lung Cancer - Alex Molassiotis, UK
• Aspects of (Nursing) Care of Patients with a Different Ethnical Background (for Netherlands for Instance Turkey, Morocco) - Fuusje de Graaff, Netherlands
• How are Lung Cancer Nurses Organized? (Netherlands, USA, UK & Australia) - Albert Olijve, Netherlands, Patricia Palmer, USA, John McPhelim, UK & Mary Duffy, Australia
• How Can/Should Lung Cancer Nurses Play a Role Within the IASLC? - Liz Darlison, UK & Peter Goldstraw, UK

E08: Education Session: Biology of Radiotherapy - An Update
Chairs: Martin Stuschke, Germany & Michael MacManus, Australia

Location: E104-E105

• Stem Cell and Radioresistance - Max Diehn, USA
• Immunogenic Cell Death and Cancer Treatments - Nathalie Chaput, France
• Targeting Galectin-1 in Non-Small cell Lung Cancer - Quynh Thu Le, USA
• SBRT for Central Lung Tumors: Radiobiological Modeling and Emerging Clinical Data - Andrea Bezjak, Canada

M07: Mini Symposium: Tumor and Host
Chairs: Tetsuya Mitsudomi, Japan & Christian Manegold, Germany

Location: Elicium II

• Epithelial-Mesenchymal Transition: From Diagnosis to Therapy - Giuseppe Pelosi, Italy
• Circulating Tumor Cells and the Metastatic Process - Klaus Pantel, Germany
• Harnessing the Immune System to Treat Cancer - Lee M Krug, USA
• Angiogenesis and the Metastatic Process - John Heymach, USA

M08: Mini Symposium: Symptom Control - Translating Basic Research to Bedside
Chairs: Richard Gralla, USA & David Currow, Australia

Location: Elicium I

• Scientific Basis for the Management of Dyspnea - David Currow, Australia
• Pain - Sam Ahmedzai, UK
• Cachexia - Robert Milroy, UK
• Chemotherapy-Induced Nausea and Vomiting: From Transmitters and Receptors to Evidence-Based Clinical Guidelines - Jorn Herrstedt, Denmark

M09: Mini Symposium: Developments in High Dose Radiotherapy for Lung Cancer
Chairs: Andrew Turrisi, USA & David Palma, Canada

Location: G102-G103

• Heavy Iron Radiotherapy in Lung Cancer - Hirohiko Tsujii, Japan
• Arc-Therapies and Other Approaches for IMRT - Wilko Verbakel, Netherlands
• Lung SBRT and Population-Based Comparative-Effectiveness Research - David Palma, Canada
• Normal Tissue Constraints for SBRT - Kenneth Rosenzweig, USA

M10: Mini Symposium: Molecular Screening
Chairs: Peter Snijders, Netherlands & Peter Mazzone, USA

Location: G104-G105

• Early Detection and Screening of Lung Cancer via Volatile Biomarkers - Hossom Haick, Israel
• Autoantibody Detection in Serum - Samir Hanash, USA
• Analysis Methylated DNA in Sputum - Steven Belinsky, USA
• Micro RNA Detection in Sputum - Feng Jiang, USA

M11: Mini Symposium: Design of Phase II Clinical Trials: Single Arm, Randomized, Multi Arm?
Chairs: Nagahiro Saijo, Japan & Roy Herbst, USA

Location: Auditorium

• Randomized Design - Harm van Tinteren, Netherlands
• Multi Arms Studies - Mahesh Parmar, UK
• Biomarker-Based Bayesian Adaptive Designs for Targeted Agent Development - Jack Lee, USA
• Phase II into Phase III - Mary Redman, USA
• Discussion - all speakers

18:30 - 20:00

Personalized Medicine in NSCLC: Myth or Reality? CMI Education Institute Satellite Symposium supported by Merck Serono

Location: Plenary Hall

• Symposium supported by Response Genetics: Biomarker-Driven Prospective Clinical Trial Design: Use of Genetic Information to Enhance Patient Benefit in the Clinical Setting

Location: Forum

• Symposium supported by Daiichi Sankyo: c-MET - An Important New Target for Lung Cancer Therapy

Location: Elicium I

• MTE10: Chemoprevention: Randomized Studies & What Have We Learned - Eva Szabo, USA & Edward Kim, USA

Location: E103

• MTE11: Critical Perspective on the Treatment of Stage IV Disease, Cost-Effectiveness Analysis New Drugs - William Evans, Canada & Penella Woll, UK

Location: E104-E105

• MTE12: Chemotherapy of Malignant Mesothelioma - Sjaak Burgers, Netherlands & Hedy Lee Kindler, USA

Location: E106

• MTE13: Pathology for Non Pathologists - Kirk Jones, USA

Location: E107

• MTE14: Pre-Neoplastic Disease - Sylvie Lantuejoul, France

Location: E108

• MTE15: Major Airway Problems - Lutz Freitag, Germany & Mark De Groot, South Africa

Location: G102

• MTE16: Radiation Pulmonary Toxicity: Prediction and Prevention - Laurie Gaspar, USA

Location: G103

• MTE17: Combined Modality Treatment, Especially Concomitant Chemoradiation: Which Chemotherapy? Which Radiotherapy Fractionation Scheme? Toxicities? - Wilfried Eberhardt, Germany & Martin Stuschke, Germany

Location: G104

• MTE18: Lymphnode Dissection - Mark S. Allen, USA & Hisao Asamura, Japan

Location: G105

PL02: Lung Cancer in Never-Smokers
Chairs: Nico van Zandwijk, Australia & Keunchil Park, Korea

Location: Plenary Hall

• Environmental Factors Contributing to Lung Cancer in Never-Smokers - Michael Thun, USA
• Molecular Pathology of Lung Cancer in Never-Smokers - Pierre P. Massion, USA
• Lung Cancer in Non-Smoking Asian Females - Caicun Zhou, China
• Lung Cancer in Never-Smokers: Prognostic Implications - Ping Yang, USA

10:00 - 11:00

IASLC Press Conference - Biomarkers and Personalized Therapy

Location: G109

10:00 - 10:30

Coffee Break

Location: Exhibit Hall

GR02: Grand Rounds Session: Difficult Surgery
Chair: Ugo Pastorino, Italy & Eric Vallieres, USA

Location: E102

• Local Recurrence after Definitive Chemoradiation: Is Salvage Surgery? - Jack A. Roth, USA
• Surgery for Complications of High Dose Radiotherapy - David Harpole, USA
• Circulatory Complications after Pneumonectomy - Anton Vonk Noordegraaf, Netherlands
• Pancoast Tumors - Hiroshi Date, Japan

PC01: Pro-Con Sessions: Endoscopic Highlights
Chairs: Masahiro Tsuboi, Japan & York Miller, USA

Location: Forum

• TBNA is the Issue, not EBUS Guided - Kazuhiro Yasufuku, Canada & Ko-Pen Wang, USA
• Auto fluorescence Early Detection is not for Clinical Practice - Valerie Rusch, USA & Eric Edell, USA

HOD01: Highlight of the Day Session: Highlights of Monday

Location: Auditorium

• Medical Oncology - Thierry Le Chevalier, France
• Surgery - Peter Goldstraw, UK
• Radiotherapy - David Ball, Australia

O14: Oral Session: Molecular Pathology: NSCLC Subtyping

Location: E103

O15: Oral Session: Cancer Stem Cells and miRNA

Location: E104-E105

O16: Oral Session: Biomarkers II

Location: E106

O17: Oral Session: Non Invasive Early Detection Methods

Location: E107

O18: Oral Session: New Image Guided Approaches for Tumor Characterization and Prediction of Therapy Outcome in NSCLC

Location: E108

O19: Oral Session: Medical Oncology II

Location: Elicium I

O20: Oral Session: Surgery - Techniques

Location: Elicium II

O21: Oral Session: Nursing I

Location: D201

O22: Oral Session: Technology and Models

Location: D202

MO07: Mini Oral Session: Biomarkers, Chemotherapy and Radiotherapy in Mesothelioma

Location: G102

MO08: Mini Oral Session: Radiation Oncology

Location: G103

MO09: Mini Oral Session: Medical Oncology I

Location: G104

MO10: Mini Oral Session: Classical Pathology

Location: G105

MO11: Mini Oral Session: Preclinical Models II

Location: G106

MO12: Mini Oral Session: End of Life Care

Location: G107

12:00 - 13:00

Coffee Break

Location: Exhibit Hall

12:15 - 13:00

IASLC Business Meeting - Light Lunch provided

Location: Elicium I

12:15 - 14:00

Poster and ePoster Session (Exhibit Hall)

Poster presenters are available to discuss their Poster with delegates

Poster Session P2

Topics

• Preclinical Models
• Imaging
• Prognostic & Predictive Markers

ePosters

Mini Oral presenters are available at pre-defined ePoster stations to discuss their extended Mini Oral presentation being presented in the Mini Oral Sessions from 10:30 to 12:00 that day (corresponding Mini Oral Sessions MO07 - MO12

13:30 - 15:30

Longkanker, waar staan we? - Lung Cancer, where do we stand? - Refreshments provided

(Session in Dutch only)

Location: Auditorium

Programme:

• Improving Lung Cancer Care
• Highlights of the Congress
• Early detection of Lung Cancer
• The quest for information and support on the Internet
• Presentation of the new book ‘200 questions from patients about lung cancer’

14:00 - 16:00

Advocacy in Action: International Forum Focus on Lung Cancer - Refreshments provided

Location: E108

Filmed session moderated by: Selma Schimmel, CEO Vital Options

Featuring IASLC Advocacy Award Scholarship Winners: Australian Lung Foundation; Jill’s Legacy; Health Alert Organization; Uniting Against Lung Cancer; Lung Cancer Foundation of America

All advocates and lung cancer professionals are invited to attend and participate in this forum.  This session of Advocacy in Action will be filmed, professionally edited and available online following the conference and will be available for posting on your websites and for social media distribution.  Advocacy in Action is an opportunity for your voice to be heard and for your organization to contribute to video content that will both benefit your organizations, and further our collective cancer advocacy efforts.  Vital Options is an international non-profit cancer communications organization that works with the patient advocacy and professional oncology community throughout the United States and Europe.  Its programs enable patients and their loved ones to connect with leading worldwide oncology opinion leaders regarding the latest advances in cancer treatment, research, advocacy, and public policy issues.     

14:00 - 16:00

IASLC Task Force - Lung Cancer CT Screening and Biomarkers Workshop

Location: Elicium I

The IASLC EDPC Lung Cancer Biomarkers Workshop was held prior to the WCLC with invited experts, who covered many of the lung cancer biomarkers which could be potentially utilized in future clinical trials. The IASLC EDPC Lung Cancer CT Screening Workshop was also held prior to the WCLC with invited experts, who participated in many of the international CT screening trials.

This session will summarize the discussions and findings of these two workshops.

13:30 - 18:00

Social Excursions (Ticket required)

Staggered departure times - please see your ticket for departure time and location.

19:15 - 20:00

Gala Reception

Location: Foyer Plenary Hall

20:00 - 23:30

Gala Dinner (Ticket required)

Location: Plenary Hall

Concurrent Meet the Expert (MTE) Sessions
*Pre-registration required
**Breakfast is provided

• MTE19: Lung Cancer in Never-Smokers: Implications for Treatment - Mark Kris, USA & Keunchil Park, Korea

Location: E102

• MTE20: How to Report PET - Emile E. Comans, Netherlands & Wolfgang Weber, Germany

Location: E103

• MTE21: Progressive Disease during TKI - Michael Cullen, UK & Tony Mok, Hong Kong

Location: E104-E105

• MTE22: ALK Translocations - Tetsuya Mitsudomi, Japan

Location: E106-E107

• MTE23: Pulmonary Cytology, Diagnosis and Molecular Approaches - Kim Geisinger, USA

Location: E108

• MTE24: New Imaging Techniques - Luc Thiberville, France & Johannes de Boer, Netherlands

Location: G102

• MTE25: Considerations in Setting Up a SBRT Program at my Clinic - Michael Snee, UK & Maria Werner Wasik, USA

Location: G103

• MTE26: Bi- Versus Trimodality Therapy for Locally Advanced NSCLC - Caro Koning, Netherlands & Pierre-Emmanuel Falcoz, France

Location: G104-G105

• MTE27: Chest Wall Tumors, Non Pancoast - Alain Chapelier, France & Cengiz Gebitekin, Turkey

Location: G106-G107

08:30 - 10:00

PRS: Presidential Symposium incl. Best Oral Presentations
Chairs: David Gandara, USA & Giorgio Scagliotti, Italy

Location: Plenary Hall

Abstracts:

P.Hammerman: Genomic Characterization and Targeted Therapeutics in Squamous Cell Lung Cancer

Discussant: Kwun Fong, Australia

C.Haasbeek: Improvements in Survival of Elderly Patients with Stage I NSCLC in the Netherlands between 2003-2009

Discussant: Hak Choy, USA

I.Bahce: In Vivo Selection of non-small Cell Lung Cancer Patients with Activating Mutations in the Tumor Epidermal Growth Factor Receptor using [11C]erlotinib and Positron Emission Tomography

Discussant: Luis Paz Ares, Spain

K.Lau: The Effects of Investing in Thoracic Surgery on Lung Cancer Resection Rates

Discussant: Jack A. Roth, USA

10:00 - 11:00

IASLC Press Conference - Improvements in Care

Location: G109

10:00 - 10:30

Coffee Break

Location: Exhibit Hall

E09: Education Session: Assessment and Measurement of Outcomes in Supportive Care
Chairs: Paul Glare, USA & David Currow, Australia

Location: E104-E105

• Quality of Life - Richard Gralla, USA
• Psychological Distress - Mari Lloyd-Williams, UK
• Quality of Palliative Care Services - Kris Vissers, Netherlands
• Palliative Sedation in the Netherlands in Guidelines and Practice - Bregje Onwuteaka-Philipsen, Netherlands

E10: Education Session: Concurrent CT-RT for LA-NSCLC - Managing Toxicity and Follow-Up
Chairs: Jose Belderbos, Netherlands & Jeff Bradley, USA

Location: E106-E107

• Pneumonitis, Esophagitis and Other Supportive Care (Feeding Tubes, When and How)? - Jeff Bradley, USA
• Predictors and Management of Late Radiation Injury to the Chest Wall and Bronchus - Lawrence Marks, USA
• PET Assessment after Chemoraditotherapy (Downstaging, Recurrences Local and Distant) - Sigrid Stroobants, Belgium
• Role of Salvage Therapy: Surgery for Recurrence, Persistent Disease, Cavitation - Marinus Paul, Netherlands

E11: Education Session: Surgery After Induction Therapy IIIA
Chairs: Gavin Wright, Australia & William T. Sause, USA

Location: E102

• Chemotherapy as Induction is Enough - Martin Reck, Germany
• Chemotherapy as Induction is Better, or, to put it Appropriately, More Promising - Hideo Kunitoh, Japan
• Restaging After Induction: Is it Needed? - Felix Herth, Germany
• Surgery After Induction: When and How? - Joe B. Putnam, USA

E14: Education Session: Lung Cancer Nursing During and After Treatment
Chairs: Mary Duffy, Australia & Albert Olijve, Netherlands

Location: E103

• A Multi-Professional Health and Well Being Clinic - Vanessa Beattie, UK
• Nursing Aspects of Treatment with (EGFR) TKI: Toxicity in Patients Treated for 6 Months & Immediate Toxicity - Atie van Wijk, Netherlands & Suzan van Spijk, Netherlands
• Maintenance Therapy: How Does My Patient Feel About It? - Lies Peeters, Belgium
• Structural Management of Patients Treated with Chemo-Radiotherapy - Wilma Uyterlinde, Netherlands

M12: Mini Symposium: Novel Therapies in NSCLC
Chairs: Jin Soo Lee, Korea & Paul Bunn, USA

Location: Elicium II

• Novel Targets and Therapies - Pasi Janne, USA
• Novel Therapies - Tony Mok, Hong Kong
• Predictive Factors - Jean-Charles Soria, France
• Intermediate (Imaging) Endpoints - Egbert Smit, Netherlands

M13: Mini Symposium: Methodological Aspects of Mutation Analysis
Chairs: Keith M. Kerr, UK & Paul Waring, Australia

Location: G102

• Overview of Techniques and Quality Control - Marc Ladanyi, USA
• Handling of Different Samples: Cytology, Biopsies, Resection Specimen - Koji Tsuta, Japan
• Detection in Blood/Serum - Miquel Taron, Spain
• Heterogeneity EGFR in Lung Cancer - Erik Thunnissen, Netherlands

M14: Mini Symposium: Image Guided Tissue Characterization
Chairs: Norihiko Ikeda, Japan & Henri Colt, USA

Location: G104-G105

• Navigational Targeting - Fumihiro Asano, Japan
• Optical Coherence Tomography - Johannes de Boer, Netherlands
• Confocal Imaging - Luc Thiberville, France
• PET/CT/MRI - Otto Hoekstra, Netherlands

M15: Mini Symposium: Nodule Management
Chairs: James Jett, USA & Denise Aberle, USA

Location: Elicium I

• Guidelines for CT-Detected Nodules - David Midthun, USA
• Volumetrics and Advanced Imaging - Rob van Klaveren, Netherlands
• Role of PET in Screen-Detected Modules - Jeremy J. Erasmus, USA
• Therapeutical Approach to Nodules in Screening Trials - Ugo Pastorino, Italy

M16: Mini Symposium: The Use of Biomarkers in Clinical Trial Design
Chairs: Ming Tsao, Canada & Nicholas Thatcher, UK

Location: G103

• The Statistician Perspective - Marc Buyse, Belgium
• Biomarkers in Clinical Trial Design - Role of the Molecular Pathologist Biologist - Ming Tsao, Canada
• The Medical Perspective - Rafal Dziadziuszko, Poland
• Discussion - Stefan Michiels, Belgium

M17: Mini Symposium: New Kids on the Block
Chairs: Ramon Rami-Porta, Spain & Eric Lim, UK

Location: G106-G107

• CITES: The Use of Flexible Scopes - Dominique Grunenwald, France
• Cervical Approach: Staging and Resections - Marcin Zielinski, Poland
• VATS Sleeve-Resections - Bernward Passlick, Germany
• Robotic Resections - Kemp H. Kernstine, USA

GR03: Grand Rounds Session: Mesothelioma - Oncological and Supportive Management
Chairs: Sam Ahmedzai, UK & Walter Weder, Switzerland

Location: Forum

• Mesothelioma - Dilemmas in Oncological Management - Jan van Meerbeeck, Belgium, Sjaak Burgers, Netherlands & Paul Baas, Netherlands
• Mesothelioma - Pain - Cordotomy - Pleural Effusion - Symptomatic Management/Destructive Pain Surgery for Intractable Chest Pain in Lung Cancer (Mesothelioma) - Gary Lee, Australia & Yucel Kanpolat, Turkey

HOD02: Highlight of the Day Session: Highlights of Tuesday

Location: Auditorium

• Medical Oncology - Juergen Wolf, Germany
• Pulmonary - Kwun Fong, Australia
• Radiotherapy - Ritsuko Komaki, USA

12:15 - 14:15

Poster and ePoster Session (Exhibit Hall)

Poster presenters are available to discuss their Poster with delegates

Poster Session P3

Topics

• NSCLC - Advanced Stage
• NSCLC - Early Stage
• SCLC
• Mesothelioma, Thymoma and Other Thoracic Malignancies

ePosters

Mini Oral presenters are available at pre-defined ePoster stations to discuss their extended Mini Oral presentation being presented in the Mini Oral Sessions from 14:30 - 16:00 that day (corresponding Mini Oral Sessions MO13 - MO18)

12:15 - 14:15

prIME Oncology Symposium supported by Roche: Practical Approaches to Non Small Cell Lung Cancer Management in the Era of Personalized Therapy

Location: Plenary Hall

O23: Oral Session: Tri - and Biomodality

Location: Auditorium

O24: Oral Session: Surgery - Outcomes

Location: Forum

O25: Oral Session: NSCLC - Early Stage

Location: E102

O26: Oral Session: Molecular Pathology I, EGFR

Location: E103

O27: Oral Session: Biomarkers and Resistance

Location: E104-E105

O28: Oral Session: Biomarkers III

Location: E106

O29: Oral Session: Nursing II

Location: E107

O30: Oral Session: Malignant Pleural Mesothelioma

Location: E108

O31: Oral Session: Medical Oncology III

Location: Elicium I

O32: Oral Session: Medical Oncology VI

Location: Elicium II

O33: Oral Session: Preclinical Models I

Location: D201

O34: Oral Session: Nodal Staging by Ultrasound Endoscopy and Alternative Image Guided Diagnosis

Location: D202

MO13: Mini Oral Session: Novel Cancer Genes and Pathways

Location: G102

MO14: Mini Oral Session: Surgery - VATS/Staging

Location: G103

MO15: Mini Oral Session: Medical Oncology II

Location: G104

MO16: Mini Oral Session: Biomarkers VII

Location: G105

MO17: Mini Oral Session: Epidemiology II

Location: G106

MO18: Mini Oral Session: Clinical Cases and Clinical Decisions II

Location: G107

16:00 - 16:30

Coffee Break

Location: Exhibit Hall

E12: Education Session: Smoking Cessation & Lung Cancer Stigma
Chairs: Ellen Gritz, USA & John Field, UK

Location: E104-E105

• Genetic Research and Smoking Behaviour - Laura Jean Bierut, USA
• Smoking Cessation as a Part of Lung Cancer Treatment - Ellen Gritz, USA
• Smoking Cessation Efforts in Asia - Bing Lam, Hong Kong
• Lung Cancer Stigma and Symptom Burden - Janine Cataldo, USA

E13: Education Session: TNM 7th Edition - What Should Doctors Do?
Chairs: William Travis, USA & Peter Goldstraw, UK

Location: E102

• Adequate pN Staging: What Should the Surgeon Do? Sampling, Radical Dissection, Systematic Nodal Dissection or Lobe-Specific Nodal Dissection? - Mark S. Allen, USA
• Adequate pN Staging: What Should the Pathologist Do? Number of Sections, Immunohisto, Molecular Markers, PCR? - Yoshihiro Matsuno, Japan
• Which Categories are Amenable for Surgery After Downstaging? - Stephen G. Swisher, USA
• Upstages Groups: Evidence for Adjuvant Therapy - Jean-Yves Douillard, France

M18: Mini Symposium: Stem Cells in the Mouse
Chairs: Anton Berns, Netherlands & Neil Watkins, USA

Location: G106-G107

• B-1 Stem Cells in Lung - Barry Stripp, USA
• Stem Cells in Murine Normal Lung and Lung Cancer - Carla Kim, USA
• HH Signaling Cancer Stem Cells - Neil Watkins, USA
• Stem Cell Chemoresistance - Luca Roz, Italy

M19: Mini Symposium: Chemoprevention: New Approaches in High Risk Populations
Chairs: Eva Szabo, USA & Fadlo Khuri, USA

Location: Elicium II

• Risk Modeling: Approaches to Populations at High Risk for Developing Lung Cancer - Margaret Spitz, USA
• Molecular Pathology of Lung Cancer & Intermediate Markers of Carcinogenesis - Ignacio Wistuba, USA
• Experimental Models and High Throughput Screening - Haian Fu, USA
• Molecular Mechanisms of Chemopreventive Compounds and Novel Approaches (Molecular Imaging) to Assess Efficacy - Fadlo Khuri, USA

M20: Mini Symposium: New Applications of Imaging Techniques
Chairs: David Shelton, USA & Kyung Soo Lee, Korea

Location: Elicium I

• New Tracers for Response Evaluation in NSCLC - Astrid van der Veldt, Netherlands
• FDG PET for Response Monitoring in NSCLC - Wolfgang Weber, Germany
• Biological Correlates of FDG Uptake - Lioe Fee de Geus-Oei, Netherlands
• Differentiation of Malignant from Benign Lung Lesions - Kyung Soo Lee, Korea

M21: Mini Symposium: Thymoma
Chairs: Egbert Smit, Netherlands & Frank Detterbeck, USA

Location: G102-G103

• Biology - Giuseppe Giaccone, USA
• Update on Thymoma Pathology - Progress achieved at the ITMIG Pathology Workshop (NYC, March, 2011) - Alexander Marx, Germany
• Staging System - Kazuya Kondo, Japan
• Chemotherapy for Thymic Malignancies - Patrick J Loehrer, USA

M22: Mini Symposium: Combination of Targeted Agents with Chemotherapy - A Challenging Task
Chairs: Robert Pirker, Austria & Wilfried Eberhardt, Germany

Location: Auditorium

• Antibodies - Thomas Lynch, USA
• IGF1R - Luis Paz Ares, Spain
• Small Molecules - Glennwood Goss, Canada

M23: Mini Symposium: Organisation of Supportive and Palliative Care to Lung Cancer
Chairs: Jesme Fox, UK & David Currow, Australia

Location: G104-G105

• Nursing Support - Liz Darlison, UK
• Hospital-Based Support Teams - Paul Glare, USA
• Early Initiation of Palliative Care - Jennifer Temel, USA
• End of Live Care - Cynthia Goh, Singapore

PC02: Pro-Con Session: Early Lung Cancer
Chairs: Joe B. Putnam & Laurie Gaspar, USA

Location: Forum

• When is Lebectomy Best? - Shun-Ichi Watanabe, Japan
• When is Limited Resection Best? - Young Mog Shim, Korea
• When is SBRT Best? - Hiroshi Onishi, Japan
• When is Radiofrequency Ablation Best? - Hiran C. Fernando, USA

18:00 - 20:00

Symposium supported by Boehringer Ingelheim: Maintaining Momentum in NSCLC Research

Location: Forum

• MTE28: How to Run a Stop Smoking Outpatient Clinic - Jacques Cornuz, Switzerland & Carolyn Dresler, USA

Location: E102

• MTE29: Second Line Treatment at Relapse of Small Cell - Pieter Postmus, Netherlands & David S. Ettinger, USA

  Location: E103

• MTE30: Genomics in Lung Cancer - Roman Thomas, Germany

Location: E104-E105

• MTE31: I Wish... Seconds to Disaster Cases to Learn From - David Fielding, Australia, Suveer Singh, UK & Bing Lam, Hong Kong

Location: E106

• MTE32: How I Practice Concurrent CT-RT for Stage III NSCLC: Patient Selection, Toxicity Management and Outcomes at My Center? - Hak Choy, USA & Francoise Mornex, France

Location: E107

• MTE33: Superior Sulcus Tumor with N2 Disease - Kemp H. Kernstine, USA & Young Mog Shim, Korea

Location: E108

• MTE34: Molecular Tools, Tissue Requirements - Peter Mazzone, USA & Peter Snijders, Netherlands

Location: G102

• MTE35: Rare Mediastinal Tumors - Paul van Schil, Belgium & Hendrik Dienemann, Germany

Location: G103

• MTE36: ALK Diagnostics - Jin-Haeng Chung, Korea & Marileila Garcia, USA

Location: G106

• MTE37: Pulmonary Risk Assessment for Curative Therapy - Alessandro Brunelli, Italy

Location: G107

State of the Art
Chairs: David Jablons, USA & Pieter Postmus, Netherlands

Location: Plenary Hall

• State of the Art Surgery in 2011 - Hisao Asamura, Japan
• State of the Art Radiotherapy in 2011 - Dirk De Ruysscher, Netherlands
• State of the Art (Molecular) Pathology in 2011 - Fred Hirsch, USA
• State of the Art Medical Treatment in 2011 - David Gandara, USA

10:00 - 11:00

IASLC Press Conference - Improvements in Practice (Practice-Changing Advances)

Location: G109

10:00 - 10:30

Coffee Break

Location: Exhibit Hall

10:00 - 12:30

Poster and ePoster Session (Exhibit Hall)

Poster presenters are available to discuss their Poster with delegates

Poster Session P4

Topics

• Early Detection and Screening
• Chemoprevention
• Epidemiology
• Tobacco Control
• Advocacy
• Clinical Cases
• Nursing
• Palliative Care
• Pathology
• Combined Modality

ePosters

Mini Oral presenters are available at pre-defined ePoster stations to discuss their extended Mini Oral presentation being presented in the Mini Oral Sessions from 12:30 to 14:00 that day (corresponding Mini Oral Sessions: MO19 - MO24)

E15: Education Session: Pain Management
Chairs: Wouter Zuurmond, Netherlands & Jan van Meerbeeck, Belgium

Location: E103

• Interventional Methods Including Spinal Techniques - Wouter Zuurmond, Netherlands
• Neuropathic Pain Including Post-Surgical Pain - Eske Aasvang, Denmark
• Fast-Acting Opioids for Breakthrough Pain Management - Andrew Davies, UK

E16: Education Session: Radiotherapy Issues in Small Cell Lung Cancer
Chairs: Suresh Senan, Netherlands & Cecile Le Pechoux, France

Location: E102

• Role of Radiation in ED-SCLC - Ben Slotman, Netherlands
• What is the Optimal Radiotherapy Dose and Target Volume in LD-SCLC - Jeffrey Bogart, USA
• Chemotherapy First Line and At Recurrence - Suresh S. Ramalingam, USA
• Potential Toxicity of Prophylactic Cranial Irradiation - Cecile Le Pechoux, France

E17: Education Session: Advanced Thymoma
Chairs: Joe B. Putnam, USA & Giuseppe Giaccone, USA

Location: E104-E105

• Surgical Treatment for Thymoma with Advanced Stages - Meinoshin Okumura, Japan
• Induction Therapy for Locally Advanced Thymoma - Gregory Riely, USA
• Adjuvant Radiotherapy - Ramesh Rengan, USA
• Re-Do Surgery - Frank Detterbeck, USA

M24: Mini Symposium: EGFR Resistance
Chairs: Martin Reck, Germany & Mark Kris, USA

Location: Elicium II

• Biology - Jeffrey Engelman, USA
• Irreversible EGFR Inhibitors and Other Inhibitors - Preclinical Data - Ravi Salgia, USA
• Irreversible Inhibitors Clinical Data - Michael Boyer, Australia
• Met Inhibitors and Others - Egbert Smit, Netherlands

M25: Mini Symposium: How Molecular Pathology May Affect Diagnosis and Treatment of Lung Cancer
Chairs: Pan Chyr Yang, Taiwan & David Carbone, USA

Location: G102

• Epigenetic Changes in Lung Cancer - Elisabeth Brambilla, France
• Mi-RNA in Lung Cancer - Pan Chyr Yang, Taiwan
• Proteomics in Lung Cancer - Eric B. Haura, USA

M26: Mini Symposium: Screening by Low Dose CT
Chairs: Kwun Fong, Australia & Stephen Lam, Canada

Location: G104-G105

• NLST Results - Christine Berg, USA
• Nelson Update - Mathijs Oudkerk, Netherlands
• Danish Study Update - Jesper Pederson, Denmark
• Update of the ITALUNG Screening Study - Eugenio Paci, Italy
• Discussant - Stephen Lam, Canada

M27: Mini Symposium: Based on Long Experience: What Brings the Future?
Chairs: Frances Shepherd, Canada & Nico van Zandwijk, Australia

Location: Elicium I

• Molecular Biology - John Minna, USA
• Pathology - Adi Gazdar, USA
• Radiotherapy - Andrew Turrisi, USA
• Surgery - Harabumi Kato, Japan
• Management of Non-Small Cell Lung Cancer: 40 Years Experience - Lawrence Einhorn, USA
• Pulmonology - Stephen Spiro, UK

M28: Mini Symposium: Oligometastatic Disease
Chairs: Royce F. Calhoun, USA & Tom Treasure, UK

Location: G103

• Brain Metastases - Minesh Mehta, USA
• Adrenal, Other Sites - David Rice, USA
• Multiple Lung Tumors - Kenji Suzuki, Japan
• Pulmonary Metastasectomy for Oligometastases in Non-Lung Cancer - Tom Treasure, UK

GR04: Grand Rounds Session: Intra-Operative Decision Making
Chairs: Johan Vansteenkiste, Belgium

Location: Forum

• Pleural Lavage Cytology - Haruhiko Kondo, Japan
• Unsuspected N2 Node - Paul van Schil, Belgium
• Management of Patients with Another Pulmonary Nodules Otherwise Operable Non-Small Cell Lung Cancer - Sanghoon Jheon, Korea
• Unsuspected T4 by Extension - Walter Weder, Switzerland

HOD03: Highlight of the Day Session: Highlights of Wednesday

Location: Auditorium

• Medical Oncology - Roy Herbst, USA
• Surgery - Ryosuke Tsuchiya, Japan
• Pulmonary - Elisabeth Quoix, France

O35: Oral Session: Radiation Oncology II

Location: Auditorium

O36: Oral Session: Surgery - Treatment Proposals

Location: Forum

O37: Oral Session: Biomarkers IV

Location: E102

O38: Oral Session: Molecular Pathology IV

Location: E103

O39: Oral Session: Biomarkers V - EGFR

Location: E104-E105

O40: Oral Session: Genetic Aberrations

Location: E106

O41: Oral Session: Supportive Care

Location: E107

O42: Oral Session: NSCLC - Adjuvant Therapy

Location: E108

O43: Oral Session: Medical Oncology IV

Location: Elicium I

O44: Oral Session: NSCLC - Advanced Stage and Statistics

Location: Elicium II

O45: Oral Session: Pleural and Central Airways Management

Location: D202

O46: Oral Session: Late Breaking Abstracts

Location: D201

MO19: Mini Oral Session: SCLC II

Location: G102

MO20: Mini Oral Session: Surgery - Outcome

Location: G103

MO21: Mini Oral Session: Medical Oncology III

Location: G104

MO22: Mini Oral Session: Biomarkers VIII

Location: G105

MO23: Mini Oral Session: Medical Oncology

Location: G106

MO24: Mini Oral Session: New Imaging Techniques and New Applications of Established Imaging Techniques in Thoracic Malignancies

Location: G107

Thank you for attending the 14th World Conference on Lung Cancer. We hope to see you again at the 15th World Conference on Lung Cancer 2013 in Sydney, Australia.

- MARK YOUR CALENDAR TO ATTEND -